Elevated expression levels of four proteins in the integrin α6β4-UCHL1-HIF1A-PTPRZ1 axis, in particular, negatively associated with RFS for breast cancer patients with treatment, suggesting that the expression signature of these four genes has prognostic value for treatment of breast cancer patients. The gene discussed is PTPRZ1; the disease is breast carcinoma.